Success Metrics

Clinical Success Rate
87.2%

Based on 34 completed trials

Completion Rate
87%(34/39)
Active Trials
3(6%)
Results Posted
26%(9 trials)
Terminated
5(9%)

Phase Distribution

Ph phase_1
6
11%
Ph not_applicable
20
38%
Ph phase_2
7
13%
Ph phase_4
9
17%
Ph phase_3
7
13%

Phase Distribution

6

Early Stage

7

Mid Stage

16

Late Stage

Phase Distribution49 total trials
Phase 1Safety & dosage
6(12.2%)
Phase 2Efficacy & side effects
7(14.3%)
Phase 3Large-scale testing
7(14.3%)
Phase 4Post-market surveillance
9(18.4%)
N/ANon-phased studies
20(40.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.2%

34 of 39 finished

Non-Completion Rate

12.8%

5 ended early

Currently Active

3

trials recruiting

Total Trials

53

all time

Status Distribution
Active(4)
Completed(34)
Terminated(5)
Other(10)

Detailed Status

Completed34
unknown10
Terminated5
Recruiting2
Not yet recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
53
Active
3
Success Rate
87.2%
Most Advanced
Phase 4

Trials by Phase

Phase 16 (12.2%)
Phase 27 (14.3%)
Phase 37 (14.3%)
Phase 49 (18.4%)
N/A20 (40.8%)

Trials by Status

not_yet_recruiting12%
unknown1019%
terminated59%
active_not_recruiting12%
completed3464%
recruiting24%

Recent Activity

Clinical Trials (53)

Showing 20 of 53 trialsScroll for more
NCT06238882Not Applicable

Nitroglycerin Plus Radiotherapy Versus Conventional Radiotherapy in Patients With Lung Cancer.

Recruiting
NCT02425566Phase 1

Role of Sympathetic Activity and Splanchnic Capacitance in Hypertension

Active Not Recruiting
NCT03026101Not Applicable

Understanding the Pathophysiology of Migraine Pain

Terminated
NCT05031520

PericOronary INflammaTion in Non-Obstructive Coronary Artery Disease

Terminated
NCT05443061Not Applicable

Subcutaneous Nitroglycerin to Prevent Radial Artery Occlusion in Children

Completed
NCT06925763Not Applicable

Effect of Nitroglycerin Hydrogel on Repairing Critical Bone Defects

Not Yet Recruiting
NCT03689946Phase 3

Effect of Evolocumab on Coronary Atherosclerosis

Completed
NCT06259760

AKI Risk Factors Analysis After Intentional Hypotensive Anesthesia

Recruiting
NCT04564521Not Applicable

Nitroglycerin for Intra-arterial Chemotherapy in Pediatric Retinoblastoma.

Unknown
NCT06107465Phase 2

High Versus Low Dose Nitroglycerin in Acute Pulmonary Edema

Unknown
NCT05718310Not Applicable

Habituation of the Nociceptive Blink Reflex in Experimentally Induced Migraine Attack

Unknown
NCT05682716Not Applicable

Application of Intraoperative Transesophageal Echocardiography Imaging of Vein and CLCVP in Early Prediction and Intervention CSA-AKI

Completed
NCT04953156

Nitroglycerine Versus Dexmedetomidine Infusion in Intraoperative Management of Uncontrolled Hypertension

Completed
NCT02209636Phase 4

Phosphate Lowering in CKD Trial

Completed
NCT05442931Phase 1

Comparison Between Pregabalin and Magnesium Sulfate in Hypotensive Anaesthesia

Unknown
NCT04686760Not Applicable

Efficacy of Inhaled Nitroglycerin in Moderate to Critically Ill COVID-19 Patients

Completed
NCT02617550Phase 1

Vericiguat Drug-drug Interaction With Nitroglycerin in Stable Coronary Artery Disease Patients

Completed
NCT04948957

Changes in Cerebral Oxygenation and Cognitive Functions

Completed
NCT04918563Not Applicable

Endothelium Dependent and Non-dependent Vasodilatation in Human Gingiva

Completed
NCT04594629Phase 1

PGI2 Versus Nitroglycerine for Management of Pulmonary Hypertension After Valve Surgeries

Unknown

Drug Details

Intervention Type
COMBINATION PRODUCT
Total Trials
53